Edition:
United States

UMN Pharma Inc (4585.T)

4585.T on Tokyo Stock Exchange

1,012JPY
2 Dec 2016
Change (% chg)

¥-26 (-2.50%)
Prev Close
¥1,038
Open
¥1,030
Day's High
¥1,035
Day's Low
¥1,007
Volume
169,800
Avg. Vol
206,823
52-wk High
¥2,755
52-wk Low
¥881

4585.T

Chart for 4585.T

About

UMN Pharma Inc. is a Japan-based biotechnology company mainly engaged in the biopharmaceuticals development business. The Company is engaged in the development, manufacture and sale of biopharmaceuticals based on the baculovirus expression vector system (BEVS) manufacturing platform. The Company's pipelines include seasonal... (more)

Overall

Beta: 2.72
Market Cap(Mil.): ¥11,818.17
Shares Outstanding(Mil.): 11.40
Dividend: --
Yield (%): --

Financials

  4585.T Industry Sector
P/E (TTM): -- 42.21 29.87
EPS (TTM): -304.07 -- --
ROI: -54.05 -1.09 14.95
ROE: -1,229.42 -2.39 16.29

BRIEF-UMN Pharma announces exercise of options

* Says 250,000 units of its 19th series options were exercised to 250,000 shares of its common stock on Aug. 24

Aug 25 2016

BRIEF-UMN Pharma announces exercise of options

* Says 200,000 units of its 19th series options were exercised to 200,000 shares of its common stock, comprised of 100,000 shares at exercise price 1,040 yen on Aug. 17 and 100,000 shares at exercise price 1,037 yen on Aug. 24

Aug 24 2016

BRIEF-UMN Pharma announces exercise of options

* Says 200,000 of 19th warrants were exercised into 200,000 shares of its common shares from July 1 to July 11, comprised of 100,000 shares at exercise price 1,375 yen and 100,000 shares at 1,364 yen

Jul 11 2016

BRIEF-UMN Pharma signs basic agreement with Protein Sciences

* Says it signed basic agreement with Protein Sciences Corporation regarding vaccine development for zika virus infection

Jun 28 2016

Earnings vs. Estimates